RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
38 hedge funds and large institutions have $248M invested in RAPT Therapeutics in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 2 closing their positions.
600% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 2
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
41% more funds holding
Funds holding: 27 → 38 (+11)
0.77% more ownership
Funds ownership: 5.23% → 6% (+0.77%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $252M → $248M (-$3.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.9M |
| 2 |
BlackRock
New York
|
+$13.7M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
+$7.61M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.89M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$3.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$828K |
| 2 |
Morgan Stanley
New York
|
-$77.2K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$68.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$38.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$26K |
RAPT Hedge Fund Activity: Q1 2020 in Review
38 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q1 2020, worth a combined $248M — down 1.4% from $252M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new RAPT positions and 2 closed out — a net gain of 12 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $33.9M. The largest seller was Norges Bank, exiting entirely with an estimated $828K sold.
- 38 institutional investors held RAPT Therapeutics (RAPT) as of Q1 2020, up from 27 in Q4 2019.
- Funds reported $248M of RAPT Therapeutics stock for Q1 2020, down 1.4% quarter-over-quarter.
- 14 funds opened new RAPT Therapeutics positions in Q1 2020 and 2 closed out, a net change of +12 holders.
- The largest RAPT Therapeutics buyer in Q1 2020 was Wellington Management Group, an estimated $33.9M added.
- The largest RAPT Therapeutics seller in Q1 2020 was Norges Bank, an estimated $828K sold.
Based on aggregated 13F filings for Q1 2020.